Literature DB >> 2480917

Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface.

G P Borisova1, I Berzins, P M Pushko, P Pumpen, E J Gren, V V Tsibinogin, V Loseva, V Ose, R Ulrich, H Siakkou.   

Abstract

Insertion of foreign oligopeptide sequences (40-50 amino acids in length) into the Pro144 position of hepatitis B core antigen (HBcAg) leads to the formation of chimeric capsids in Escherichia coli cells. These capsids are morphologically and immunologically similar to native HBcAg, but expose the inserted oligopeptides on their outer surface and exhibit antigenic and immunogenic characteristics of the latter. As a source of model antigenic determinants, the appropriate DNA copies excised from cloned viral genes such as the pre-S region of hepatitis B virus, the transmembrane protein gp41 of human immunodeficiency virus 1 and the envelope protein gp51 of bovine leukemia virus have been used. The localization of the inserted antigenic determinants on the surface of chimeric capsids does not depend on the presence or absence of the arginine-rich, 39 amino acid-long C terminus of HBcAg.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480917     DOI: 10.1016/0014-5793(89)81509-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  The affinities of monoclonal antibodies against core antigen of hepatitis B virus.

Authors:  U Apsalons; V Bichko
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

2.  T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles.

Authors:  T Fehr; D Skrastina; P Pumpens; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Comparison of three different recombinant hepatitis B virus core particles expressed in Escherichia coli.

Authors:  A Maassen; A Rehfeldt; S Kiessig; A Ladhoff; W E Höhne; H Meisel
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.

Authors:  G Borisova; B Arya; A Dislers; O Borschukova; V Tsibinogin; D Skrastina; M A Eldarov; P Pumpens; K G Skryabin; E Grens
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.

Authors:  R Ulrich; G P Borisova; E Gren; I Berzin; P Pumpen; R Eckert; V Ose; H Siakkou; E J Gren; R von Baehr
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.

Authors:  C S Brown; J W Van Lent; J M Vlak; W J Spaan
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein.

Authors:  A Yoshikawa; T Tanaka; Y Hoshi; N Kato; K Tachibana; H Iizuka; A Machida; H Okamoto; M Yamasaki; Y Miyakawa
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

Review 8.  Use of hepadnavirus core proteins as vaccine platforms.

Authors:  David C Whitacre; Byung O Lee; David R Milich
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

9.  The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Authors:  F Schödel; A M Moriarty; D L Peterson; J A Zheng; J L Hughes; H Will; D J Leturcq; J S McGee; D R Milich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.

Authors:  David H Nguyen; Jianming Hu
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.